Press release
Global Recombinant Protein Therapeutics Market Research Report 2023 | Valuates Reports
Recombinant Protein Therapeutics MarketIn the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics covers drugs that are structurally proteins or peptides, as well as drugs obtained through recombinant DNA technology.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-25N13392/Global_Recombinant_Protein_Therapeutics_Market_Research_Report_2023
The global Recombinant Protein Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Recombinant Protein Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Recombinant Protein Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Recombinant Protein Therapeutics in Diabetes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Recombinant Protein Therapeutics include Eli Lilly, Pfizer, Merck, Roche, Biogen, Bayer, J&J, Amgen and Sanofi, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Therapeutics.
The Recombinant Protein Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Recombinant Protein Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Protein Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
Buy Chapters: https://reports.valuates.com/market-reports/QYRE-Auto-25N13392/global-recombinant-protein-therapeutics/1
Key Segmentations
By Company
• Eli Lilly
• Pfizer
• Merck
• Roche
• Biogen
• Bayer
• J&J
• Amgen
• Sanofi
• Ligand
Segment by Type
• Recombinant Hormones
• Interferons
• Interleukins
• Hematopoietic Growth Factors
• Others
Segment by Application
• Diabetes
• Dwarfism
• Heart Disease
• Cancer
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-25N13392/global-recombinant-protein-therapeutics
Similar Reports:
1. https://reports.valuates.com/market-reports/QYRE-Auto-6V14137/global-therapeutic-recombinant-protein
2. https://reports.valuates.com/market-reports/QYRE-Auto-6S9504/global-rice-protein
3. https://reports.valuates.com/market-reports/QYRE-Auto-21B12349/global-escherichia-coli-host-cell-protein-elisa-kit
Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Email Id:
Please reach us at sales@valuates.com
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Recombinant Protein Therapeutics Market Research Report 2023 | Valuates Reports here
News-ID: 3109120 • Views: …
More Releases from Valuates Reports
Data Center Substation Market Set to Surge - Key Insights You Must Know
Data Center Substation Market
The global market for Data Center Substation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15H10205/Global_Data_Center_Substation_Market_Research_Report_2022
North American market for Data Center Substation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of %…
Antistatic HPL Raised Floor Market Set to Surge - Key Insights You Must Know
Antistatic HPL Raised Floor Market Size
The global market for Antistatic HPL Raised Floor was valued at US$ 794 million in the year 2024 and is projected to reach a revised size of US$ 1125 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3F17863/Global_Antistatic_HPL_Raised_Floor_Market_Research_Report_2024
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent…
State-of-the-Art Data Centers Market Set to Surge - Key Insights You Must Know
State-of-the-Art Data Centers Market Size
The global market for State-of-the-Art Data Centers was valued at US$ 15430 million in the year 2024 and is projected to reach a revised size of US$ 30760 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-20U19339/Global_State_of_the_Art_Data_Centers_Market_Research_Report_2025
These data centers incorporate the latest technologies in hardware, software, and networking, including high-performance servers, advanced cooling systems, energy-efficient designs, and robust cybersecurity…
AI Server GPU Market Set to Surge - Key Insights You Must Know
AI Server GPU Market Size
The global market for AI Server GPU was valued at US$ 1430 million in the year 2024 and is projected to reach a revised size of US$ 4154 million by 2031, growing at a CAGR of 16.7% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-34U16081/Global_AI_Server_GPU_Market_Research_Report_2024
This report aims to provide a comprehensive presentation of the global market for AI Server GPU, with both quantitative and qualitative analysis, to…
More Releases for Recombinant
Recombinant Human Endostatin Market Experiences Surge Due to Innovations in Reco …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Human Endostatin Market - (By Type (purity 95% and others) And By Application (medical care, scientific research and others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to…
Recombinant Chemicals Market Expands with Growing Adoption of Recombinant DNA an …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Chemicals Market - (By Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), By Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), By Application (Drug Development, Vaccine Production, Therapeutics, Cell Line Development, Agriculture, Food and Beverage, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
Recombinant Collagen Market Outlook and Investment Analysis
Top companies
Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies
Recombinant Collagen Market: Trends & Investment Analysis
Market Growth: The recombinant collagen…
Global Recombinant Cell Culture Supplements Market Size - By Product Type(Recomb …
Recombinant Cell Culture Supplements Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Recombinant Cell Culture Supplements Market Scope: Unveiling Today's Trends
Recombinant Cell Culture Supplements are specialized products designed to enhance growth and productivity in cells used for research and bioproduction.
The market for these supplements is experiencing substantial growth, driven by the rising demand for biopharmaceuticals and advancements in biotechnology. Increasing investments in research and development activities also contribute to market…
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The next…
